|
Hosmer–Lemeshow goodness-of-fit test values: time point for which the scores were developed |
|||||||
| Score |
Mortality probability classes (%) |
Expected deaths |
Observed deaths |
Observed survivors |
Expected survivors |
χ2 goodness-of-fit test values |
SMR (95% CI) |
|
|
|||||||
| PIM 1 hour |
<1 |
1.3 |
3 |
175 |
176.7 |
2.2 |
|
| 1 to <5 |
8.3 |
15 |
357 |
363.7 |
5.5 |
||
| 5 to <15 |
12.2 |
23 |
127 |
137.9 |
10.4 |
||
| 15 to <30 |
13.0 |
15 |
47 |
49.0 |
0.4 |
||
| ≥30 |
22.8 |
24 |
16 |
17.2 |
0.1 |
||
| Totals |
57.6 |
80 |
722 |
744.7 |
18.7 |
1.39 (1.10–1.73)* |
|
| PRISM 24 hours |
<1 |
1.5 |
4 |
237 |
239.5 |
4.2 |
|
| 1 to <5 |
7.7 |
16 |
313 |
321.3 |
9.2 |
||
| 5 to <15 |
10.2 |
9 |
112 |
110.8 |
0.2 |
||
| 15 to <30 |
8.5 |
7 |
33 |
31.5 |
0.3 |
||
| ≥30 |
49.5 |
44 |
27 |
21.5 |
2.0 |
||
| Totals |
77.4 |
80 |
722 |
724.6 |
15.9 |
1.03 (0.82–1.29) |
|
| PRISM III 12 hours |
<1 |
1.8 |
4 |
422 |
424.2 |
2.7 |
|
| 1 to <5 |
4.4 |
14 |
175 |
184.6 |
21.4 |
||
| 5 to <15 |
7.5 |
10 |
75 |
77.5 |
0.9 |
||
| 15 to <30 |
7.2 |
5 |
27 |
24.8 |
0.9 |
||
| ≥30 |
51.1 |
47 |
23 |
18.9 |
1.2 |
||
| Totals |
72.0 |
80 |
722 |
730.0 |
27.1 |
1.11 (0.88–1.38) |
|
| PRISM III 24 hours |
<1 |
1.7 |
3 |
474 |
475.3 |
1.0 |
|
| 1 to <5 |
3.3 |
12 |
133 |
141.7 |
23.5 |
||
| 5 to <15 |
7.0 |
14 |
72 |
79.0 |
7.7 |
||
| 15 to <30 |
6.2 |
5 |
25 |
23.8 |
0.3 |
||
| ≥30 |
48.6 |
46 |
18 |
15.4 |
0.6 |
||
| Totals |
66.8 |
80 |
722 |
735.2 |
33.0 |
1.20 (0.95–1.49) |
|
|
*Significantly greater than 1 (P = 0.002) [13]. CI, confidence interval; PIM, Paediatric Index of Mortality [4]; PRISM, Paediatric RISk of Mortality [1,2]; SMR, standardized mortality ratio. | |||||||
Leteurtre et al. Critical Care 2004 8:R185 doi:10.1186/cc2869 |
|||||||